Evidence map›Paper›PMID 41919938›Full record

ArticlemBio2026

TRIM25 promotes antiviral innate immune response by stabilizing IRF7 and its nuclear translocation.

Zhen Wu, Yingxuan Cui, Yu He, Tao Wang, Tao Hu, Mingshu Wang, Renyong Jia, Dekang Zhu, Mafeng Liu, Xinxin Zhao and 9 more

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zhen Wu *Institute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.ORCID 0000-0002-7081-6430
Yingxuan Cui *Institute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Yu HeInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Tao WangInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Tao HuInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Mingshu WangInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Renyong JiaInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Dekang ZhuInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.ORCID 0000-0002-7314-1088
Mafeng LiuInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.ORCID 0000-0002-6834-3128
Xinxin ZhaoInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Qiao YangInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Ying WuInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Shaqiu ZhangInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Juan HuangInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Xumin OuInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Di SunInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Bin TianInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.
Anchun ChengInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.ORCID 0000-0001-6093-353X
Shun ChenInstitute of Veterinary Medicine and Immunology, Sichuan Agricultural University, Chengdu, Sichuan, China.ORCID 0000-0002-7488-1037

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most avian species lack interferon regulatory factor 3 (IRF3), a key transcription factor that initiates antiviral interferon responses, leaving how they achieve rapid RNA virus defense unclear. Here, we identify duck tripartite motif containing 25 protein (TRIM25) as an unexpected, central activator of IRF7-dependent antiviral signaling that compensates for the absence of IRF3. Viral RNA stimulation strongly induced TRIM25 expression in duck embryonic fibroblasts (DEFs). Overexpression of TRIM25 increased IFN-β production and restricted the replication of multiple RNA viruses in DEFs and in ducklings, whereas TRIM25 knockdown enhanced viral replication (tembusu virus, TMUV, novel duck reovirus, NDRV, vesicular stomatitis virus, VSV). Mechanistically, TRIM25 functioned as an E3 ubiquitin ligase that catalyzed K27-linked polyubiquitination of IRF7 at lysine 46 (K46), thereby promoting IRF7 stability and nuclear translocation. Mutation of TRIM25 catalytic residues or of IRF7 K46 abolished these effects. In addition, TRIM25 stabilized IRF7 independently of its ligase activity by antagonizing suppressor of cytokine signaling 1 (SOCS1)-mediated degradation. Notably, TRIM25-driven signaling occurred independently of retinoic acid-inducible gene I (RIG-I) activation. Together, these findings reveal a dual regulatory mechanism by which avian TRIM25 activates IRF7 to elicit robust type I interferon (IFN-I) responses, providing a molecular explanation for rapid antiviral immunity in species lacking IRF3. IMPORTANCE: Most avian species, including those in the orders

Indexed as

Immunity, InnateInterferon Regulatory Factor-7Transcription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesAnimalsDucksFibroblastsRNA VirusesSignal TransductionUbiquitinationVirus ReplicationInterferon Regulatory Factor-7Transcription FactorsTripartite Motif ProteinsUbiquitin-Protein Ligasesinnate immunityIRF7TRIM25

Identifiers

PMID41919938
PMCPMC13170311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.